qPCR
Bio-Techne Receives IVDR Certification for Chronic Myeloid Leukemia Test
The qPCR-based test quantifies BCR-ABL1 and ABL1 transcripts in blood samples from patients with chronic myeloid leukemia to determine their response to treatment.
Sysmex, Cerca Biotech Sign Distribution Agreement on Breast Cancer Assay
The multigene RT-qPCR MammaTyper test will become available in 13 markets in Europe, expanding Cerca's reach on the continent.
Investigators from Inserm and Radboud University Medical Center are spearheading the endeavor, called HT-Advance, which is funded by the EU, the UK, and Switzerland.
SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay
The Netherlands-based firm is partnering with Belgian company Biocartis on European commercialization of the qPCR assay, which could reduce unnecessary surgeries.
The new tests, once developed, will be used for selecting patients who might best benefit from therapies for kidney disease, nonalcoholic steatohepatitis, and respiratory disease.